TherapeuticsMD (TXMD)
NASDAQ:TXMD
Holding TXMD?
Track your performance easily

TherapeuticsMD (TXMD) Financial Statements

2,226 Followers

TherapeuticsMD Financial Overview

TherapeuticsMD's market cap is currently ―. The company's EPS TTM is $-0.55; its P/E ratio is -3.11; TherapeuticsMD is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 234.00K$ 313.00K$ -53.00K$ 437.00K$ 416.00K
Gross Profit$ 234.00K$ 313.00K$ -53.00K$ 437.00K$ 416.00K
EBIT$ -2.44M$ -1.14M$ -1.41M$ -2.37M$ -2.26M
EBITDA$ -2.26M$ -1.01M$ -1.28M-$ -2.23M
Net Income Common Stockholders$ -1.09M$ -1.07M$ -3.38M$ -2.41M$ -2.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 4.34M$ 10.17M$ 13.73M$ 17.25M
Total Assets$ 40.13M$ 42.09M$ 50.49M$ 53.69M$ 59.54M
Total Debt$ 0.00$ 0.00$ 6.74M$ 6.94M$ 7.13M
Net Debt$ 0.00$ -4.34M$ -3.43M$ -6.79M$ -10.11M
Total Liabilities$ 12.46M$ 13.42M$ 22.44M$ 22.49M$ 27.58M
Stockholders Equity$ 27.67M$ 28.66M$ 28.05M$ 31.20M$ 32.02M
Cash Flow-
Free Cash Flow$ 1.45M$ -229.00K$ -6.03M-$ -8.70M
Operating Cash Flow$ 1.45M$ -229.00K$ -6.03M$ -3.39M$ -8.70M
Investing Cash Flow-----
Financing Cash Flow--$ -1.00K$ 44.00K$ 1.11M
Currency in USD

TherapeuticsMD Earnings and Revenue History

TherapeuticsMD Debt to Assets

TherapeuticsMD Cash Flow

TherapeuticsMD Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis